Form 8-K · Current Report · Filed 2024-11-08
GE HealthCare Announces Pricing of Secondary Offering
GE HealthCare Technologies Inc. announced the pricing of a secondary offering of 13,281,302 shares of its common stock on November 7, 2024. The company will not sell any shares and will not receive any proceeds from the sale. Instead, GE Aerospace is expected to exchange the shares for its indebtedness held by Morgan Stanley Bank, N.A., and subsequently, Morgan Stanley & Co. LLC intends to sell the shares to underwriters. The offering is expected to close on November 12, 2024, subject to customary conditions.
- Filer
- Ge Healthcare Technologies Inc. GEHC · NASDAQ
- Filed
- Accession
- 0001193125-24-254226
- CIK
- 0001932393
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Other Events
Financial Statements and Exhibits
Market reaction
Close before filing
$88.33
Next session
-3.3%
Since filing
-23.0%
Latest close
$68.02
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from GEHC reporting the same item, with the next session's move:
Exhibits (2)
About Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc. is a prominent player in the healthcare industry, focused on providing transformative medical technology and diagnostic solutions. Specializing in imaging, monitoring, and diagnostic equipment, the company plays a crucial role in enhancing clinical outcomes, improving patient care, and driving medical technology innovations. Ge Healthcare Technologies Inc. is recognized for its advancements in medical imaging systems, including MRI, CT, and ultrasound technologies, which aid in early disease detection and treatment planning. In addition to its hardware innovations, the company is actively involved in digital healthcare solutions, employing data analytics and AI to support precise diagnoses and personalized medicine. The impact of Ge Healthcare Technologies extends across various healthcare sectors, including hospitals, clinics, and research institutions, underscoring its importance in advancing clinical capabilities and operational efficiencies within the healthcare system. Ge Healthcare Technologies Inc. maintains a strategic presence in global markets, bolstering healthcare infrastructure and supporting public health initiatives. By continuously striving to innovate and improve healthcare delivery, it remains a significant entity within the broader medical technology and life sciences industry, contributing to the future of healthcare.
Never miss another GEHC filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.